These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 11900240)

  • 21. [Molecular subgrouping and characterization analysis of medulloblastomas in a cohort of Japanese patients].
    Wataya T; Hamasaki M; Taylor MD
    No Shinkei Geka; 2015 Feb; 43(2):117-25. PubMed ID: 25672552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of gamma-catenin expression with good prognosis in medulloblastomas.
    Misaki K; Marukawa K; Hayashi Y; Fukusato T; Minamoto T; Hasegawa M; Yamashita J; Fujisawa H
    J Neurosurg; 2005 Mar; 102(2 Suppl):197-206. PubMed ID: 16156230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An immunohistochemical study of tenascin expression in cerebellar medulloblastomas].
    Korshunov AG; Golanov AV; Sycheva RV
    Zh Vopr Neirokhir Im N N Burdenko; 1997; (4):23-7. PubMed ID: 9460893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaplasia and grading in medulloblastomas.
    Eberhart CG; Burger PC
    Brain Pathol; 2003 Jul; 13(3):376-85. PubMed ID: 12946027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma. Detection of a novel chromosomal abnormality.
    DeChiara C; Borghese A; Fiorillo A; Genesio R; Conti A; D'Amore R; Pettinato G; Varone A; Maggi G
    Childs Nerv Syst; 2002 Aug; 18(8):380-4. PubMed ID: 12192498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medulloblastoma variants and survival at a children's hospital.
    Craver R; Sandquist D; Nadell J; Velez M
    Fetal Pediatr Pathol; 2011; 30(1):53-9. PubMed ID: 21204667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas.
    McManamy CS; Lamont JM; Taylor RE; Cole M; Pearson AD; Clifford SC; Ellison DW;
    J Neuropathol Exp Neurol; 2003 Jun; 62(6):627-32. PubMed ID: 12834107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinctive MRI features of pediatric medulloblastoma subtypes.
    Yeom KW; Mobley BC; Lober RM; Andre JB; Partap S; Vogel H; Barnes PD
    AJR Am J Roentgenol; 2013 Apr; 200(4):895-903. PubMed ID: 23521467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
    Takei H; Nguyen Y; Mehta V; Chintagumpala M; Dauser RC; Adesina AM
    J Neurosurg Pediatr; 2009 Jan; 3(1):61-5. PubMed ID: 19119907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature.
    Amlashi SF; Riffaud L; Brassier G; Morandi X
    Cancer; 2003 Aug; 98(3):618-24. PubMed ID: 12879481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-internexin expression in medulloblastomas and atypical teratoid-rhabdoid tumors.
    Kaya B; Mena H; Miettinen M; Rushing EJ
    Clin Neuropathol; 2003; 22(5):215-21. PubMed ID: 14531545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
    Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
    J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histologic features and prognosis in pediatric medulloblastoma.
    Verma S; Tavaré CJ; Gilles FH
    Pediatr Dev Pathol; 2008; 11(5):337-43. PubMed ID: 18201118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group.
    Robertson PL; Muraszko KM; Holmes EJ; Sposto R; Packer RJ; Gajjar A; Dias MS; Allen JC;
    J Neurosurg; 2006 Dec; 105(6 Suppl):444-51. PubMed ID: 17184075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of prognosis in children with medulloblastoma by using immunohistochemical analysis and tissue microarray.
    Shim KW; Joo SY; Kim SH; Choi JU; Kim DS
    J Neurosurg Pediatr; 2008 Mar; 1(3):196-205. PubMed ID: 18352763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.
    Ellison DW; Onilude OE; Lindsey JC; Lusher ME; Weston CL; Taylor RE; Pearson AD; Clifford SC;
    J Clin Oncol; 2005 Nov; 23(31):7951-7. PubMed ID: 16258095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas.
    de Haas T; Oussoren E; Grajkowska W; Perek-Polnik M; Popovic M; Zadravec-Zaletel L; Perera M; Corte G; Wirths O; van Sluis P; Pietsch T; Troost D; Baas F; Versteeg R; Kool M
    J Neuropathol Exp Neurol; 2006 Feb; 65(2):176-86. PubMed ID: 16462208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome--a new clinical perspective.
    Garrè ML; Cama A; Bagnasco F; Morana G; Giangaspero F; Brisigotti M; Gambini C; Forni M; Rossi A; Haupt R; Nozza P; Barra S; Piatelli G; Viglizzo G; Capra V; Bruno W; Pastorino L; Massimino M; Tumolo M; Fidani P; Dallorso S; Schumacher RF; Milanaccio C; Pietsch T
    Clin Cancer Res; 2009 Apr; 15(7):2463-71. PubMed ID: 19276247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients.
    Korshunov A; Golanov A; Sycheva R; Timirgaz V
    Cancer; 2004 Mar; 100(6):1230-7. PubMed ID: 15022291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma.
    Lo KC; Ma C; Bundy BN; Pomeroy SL; Eberhart CG; Cowell JK
    Clin Cancer Res; 2007 Dec; 13(23):7022-8. PubMed ID: 18056178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.